United States · 
Who invested in MiNK Therapeutics?
MiNK Therapeutics's investors include National Institute of Allergy and Infectious Diseases.
United States · Venture startup
Who invested in MiNK Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2025, from 1 source
- Latest round
- VentureJun 2025
- Investors
- 1
The rounds
- Jun 2025
Founders and team
From MiNK Therapeutics's own website: 10 on the team.
- Dr. Marco PurbhooHead of Translational Medicine
- Dr. Terese HammondHead of Inflammatory and Pulmonary Diseases
- Barbara RyanDirector
- Brian CorveseDirector
- Dr. Nils RudqvistSenior Director, Research
- Hayley CullenDirector of Manufacturing
- Peter BehnerDirector
- Sandra CraigExecutive Director of Manufacturing
- Thiago FavanoSenior Director, Portfolio Operations
- Ulf WiinbergDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about MiNK Therapeutics
How much has MiNK Therapeutics raised?
MiNK Therapeutics has raised 1 round since 2025, none with a disclosed amount.
When did MiNK Therapeutics last raise?
MiNK Therapeutics's most recent round was a Venture in Jun 2025.
Who backed MiNK Therapeutics first?
MiNK Therapeutics's first round on record, in Jun 2025, was backed by National Institute of Allergy and Infectious Diseases.
What stage is MiNK Therapeutics at?
MiNK Therapeutics's latest named round is a Venture, in Jun 2025.
Where is MiNK Therapeutics based?
MiNK Therapeutics is based in the United States.
Companies like MiNK Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.